• Members
  • Activities
  • Technologies
  • News & Events
  • Search
  • Menu Menu

SmartDyeLivery receives phase I clinical trial approval

3. July 2023

The Federal Institute for Drugs and Medical Devices (BfArM) has approved SmartDyeLivery GmbH’s entry into the clinical phase after reviewing the content of the application. Thus, for the first time, nanotransporters that are being developed for a specific therapy of septic liver failure can be tested on healthy subjects in a clinical setting.

More information

https://www.joint-lab-polymers.de/wp-content/uploads/2023/05/Logo_final_RGB__weis.svg 0 0 Stephan Hünniger https://www.joint-lab-polymers.de/wp-content/uploads/2023/05/Logo_final_RGB__weis.svg Stephan Hünniger2023-07-03 08:22:482023-07-10 08:24:21SmartDyeLivery receives phase I clinical trial approval

Latest Posts

  • Bayreuth researcher develops high-performance digital system for tailoring polymers18. July 2023 - 9:00
  • A new perspective in protein research17. July 2023 - 9:00
  • A flagship of digitization: Opening ceremony for the FIM Research Institute for Information Management10. July 2023 - 9:00

Archive

  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023

Contact

Jena

Prof. Dr. Ulrich S. Schubert
Friedrich Schiller University Jena
Humboldtstraße 10
07743 Jena

Bayreuth

Prof. Dr.-Ing. Holger Ruckdäschel
University of Bayreuth
Universitätsstraße 30
95447 Bayreuth

Imprint

Data protection

© 2023 Joint Lab for Polymers Jena-Bayreuth. All Rights Reserved

Scroll to top